420 Lexington Avenue
Suite 2035
New York, NY 10170
United States
https://www.curaleaf.com
版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 5,650
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Mr. Boris Alexis Jordan | Executive Chairman | 1.75M | 無 | 1966 |
Mr. Matthew S. Darin | Chief Executive Officer | 1.06M | 無 | 無 |
Mr. Joseph F. Lusardi | Executive Vice-Chairman | 657.7k | 無 | 1974 |
Mr. Edward Kremer | Chief Financial Officer | 461.74k | 無 | 1972 |
Mr. Camilo Russi Lyon | Chief Investment Officer | 無 | 無 | 無 |
Mr. Jakob Feinstein | Manager of Investor Relations | 無 | 無 | 無 |
Mr. Peter Laurence Clateman J.D. | Chief Legal Officer | 無 | 無 | 1968 |
Mr. James S. Shorris | Chief Compliance Officer | 無 | 無 | 1961 |
Ms. Tracy Brady | Senior Vice President of Corporate Communications | 無 | 無 | 無 |
Ms. Kate Lynch | Executive Vice President of Marketing | 無 | 無 | 無 |
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.
截至 無 止,Curaleaf Holdings, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。